ArticleCurrent gene therapy2013

Identification of a therapeutic dose of continuously delivered erythropoietin in the eye using an inducible promoter system.

Jessica Hines-Beard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.